UBS AM
NVO

UBS AM’s Novo Nordisk NVO Stock Holding History

UBS AM’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38M Sell
49,624
-13
-0% -$559 ﹤0.01% 1966
2026
Q1 		$1.82M Buy
49,637
+41,712
+526% +$1.98M ﹤0.01% 2081
2025
Q4 		$403K Buy
+7,925
New +$405K ﹤0.01% 2365
2019
Q4 		– Sell
-15,246
Closed -$394K – 2739
2019
Q3 		$394K Sell
15,246
-192
-1% -$4.86K ﹤0.01% 2371
2019
Q2 		$394K Sell
15,438
-690
-4% -$17.1K ﹤0.01% 2312
2019
Q1 		$422K Sell
16,128
-3,622
-18% -$89K ﹤0.01% 2174
2018
Q4 		$455K Sell
19,750
-73,550
-79% -$1.63M ﹤0.01% 2038
2018
Q3 		$2.2M Sell
93,300
-21,480
-19% -$524K ﹤0.01% 1462
2018
Q2 		$2.65M Buy
114,780
+8,956
+8% +$213K ﹤0.01% 1388
2018
Q1 		$2.61M Buy
105,824
+4,724
+5% +$124K ﹤0.01% 1362
2017
Q4 		$2.71M Buy
101,100
+8,356
+9% +$213K ﹤0.01% 1310
2017
Q3 		$2.23M Buy
92,744
+12,046
+15% +$272K ﹤0.01% 1357
2017
Q2 		$1.73M Buy
80,698
+23,048
+40% +$465K ﹤0.01% 1419
2017
Q1 		$988K Sell
57,650
-18,218
-24% -$317K ﹤0.01% 1647
2016
Q4 		$1.36M Sell
75,868
-7,082
-9% -$128K ﹤0.01% 1442
2016
Q3 		$1.73M Sell
82,950
-54
-0.1% -$1.34K ﹤0.01% 1436
2016
Q2 		$2.23M Sell
83,004
-8,892
-10% -$244K ﹤0.01% 1325
2016
Q1 		$2.49M Buy
91,896
+83,506
+995% +$2.24M ﹤0.01% 1278
2015
Q4 		$244K Buy
+8,390
New +$232K ﹤0.01% 2440

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS AM's NVO Position: Q2 2026 in Review

UBS AM reduced its Novo Nordisk (NVO) stake by 0.03% in Q2 2026, selling an estimated $559 and leaving 49,624 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1966.

UBS AM first reported a position in NVO in Q4 2015 and has held it in 19 quarters since. The position peaked at $2.71M in Q4 2017. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • UBS AM held 49,624 shares of Novo Nordisk worth $2.38M as of Q2 2026.
  • UBS AM sold 13 Novo Nordisk shares in Q2 2026, an estimated $559.
  • Novo Nordisk made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1966 holding.
  • UBS AM first reported a position in Novo Nordisk in Q4 2015 and has held it in 19 quarters since.
  • UBS AM's Novo Nordisk position peaked at $2.71M in Q4 2017.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.